Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Greil

Showing results (51-60 of 145) with videos related to

Pageof 15
Sort By:
European Journal of Immunology|December 1, 1996
Modulation of Apo-1/Fas (CD95)-induced programmed cell death in myeloma cells by interferon-alpha 2A Egle, A Villunger, M Kos, et al.
Cell Death and Differentiation|October 13, 2001
Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblastsD Bernhard, S Skvortsov, I Tinhofer, et al.
International Archives of Allergy and Immunology|August 1, 1995
Multimodal therapy in life-threatening cerebral lupus erythematosus: the benefit of cerebrospinal fluid pheresisB Pfausler, S Bösch, G Grubwieser, et al.
Pathology, Research and Practice|July 4, 2001
Primary gastrointestinal B-cell lymphoma. A clincopathological and immunohistochemical study of 61 cases with an evaluation of prognostic parametersJ Krugmann, S Dirnhofer, A Gschwendtner, et al.
Cancer Research|August 15, 1997
Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cellsA Villunger, A Egle, M Kos, et al.
Clinical and Experimental Immunology|May 1, 1986
Receptors for the third component of complement: their association with maturation stage in non-Hodgkin lymphomas (NHL) and their possible implication with the development of follicular structuresR Greil, C Gattringer, T Schulz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30G Kemmler, B Holzner, M Kopp, et al.
Dermatology (Basel, Switzerland)|January 1, 1995
Necrotizing vasculitis associated with hepatitis C virus infection: successful treatment of vasculitis with interferon-alpha despite persistence of mixed cryoglobulinemiaN T Sepp, F Umlauft, B Illersperger, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 21, 2002
Multidimensional scaling as a tool for analysing quality of life dataG Kemmler, B Holzner, M Kopp, et al.
British Journal of Haematology|May 1, 1997
Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional statusA Egle, A Villunger, I Marschitz, et al.
Pageof 15

Showing results (51-60 of 145) with videos related to

Sort By:
Pageof 15
European Journal of Immunology|December 1, 1996
Modulation of Apo-1/Fas (CD95)-induced programmed cell death in myeloma cells by interferon-alpha 2A Egle, A Villunger, M Kos, et al.
Cell Death and Differentiation|October 13, 2001
Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblastsD Bernhard, S Skvortsov, I Tinhofer, et al.
International Archives of Allergy and Immunology|August 1, 1995
Multimodal therapy in life-threatening cerebral lupus erythematosus: the benefit of cerebrospinal fluid pheresisB Pfausler, S Bösch, G Grubwieser, et al.
Pathology, Research and Practice|July 4, 2001
Primary gastrointestinal B-cell lymphoma. A clincopathological and immunohistochemical study of 61 cases with an evaluation of prognostic parametersJ Krugmann, S Dirnhofer, A Gschwendtner, et al.
Cancer Research|August 15, 1997
Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cellsA Villunger, A Egle, M Kos, et al.
Clinical and Experimental Immunology|May 1, 1986
Receptors for the third component of complement: their association with maturation stage in non-Hodgkin lymphomas (NHL) and their possible implication with the development of follicular structuresR Greil, C Gattringer, T Schulz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30G Kemmler, B Holzner, M Kopp, et al.
Dermatology (Basel, Switzerland)|January 1, 1995
Necrotizing vasculitis associated with hepatitis C virus infection: successful treatment of vasculitis with interferon-alpha despite persistence of mixed cryoglobulinemiaN T Sepp, F Umlauft, B Illersperger, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 21, 2002
Multidimensional scaling as a tool for analysing quality of life dataG Kemmler, B Holzner, M Kopp, et al.
British Journal of Haematology|May 1, 1997
Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional statusA Egle, A Villunger, I Marschitz, et al.
Pageof 15